Cravath’s London Office Moves to 100 Cheapside
Joseph D. Zavaglia is a generalist corporate lawyer with more than 20 years of experience advising public and private companies and financial institutions across multiple disciplines, including IPOs and other capital markets transactions; leveraged loans (broadly syndicated and direct) and other complex financing arrangements; activism defense (shareholder and debtholder) and other liability management transactions; corporate governance and other Board of Director matters; public company reporting and other SEC matters; and joint ventures, acquisitions and other M&A transactions.
Diversity is a hallmark of Mr. Zavaglia’s practice. Bucking the industry trend towards specialization, Mr. Zavaglia instead maintains a broad‑based corporate practice and advises his clients on their most significant matters—regardless of industry or manner of transaction.
Mr. Zavaglia has been repeatedly recognized for his work by Chambers USA, Chambers Global, The Legal 500 US, IFLR1000 and Super Lawyers. According to clients, Mr. Zavaglia is “among the leading names in the market” with an “excellent reputation.” Clients have described him as “top-notch” and someone who “never fails to impress and delivers the best outcomes for his clients.” Mr. Zavaglia has been named by IFLR1000 as a Market Leader and recognized as both a Leading Lawyer and a Rising Star. He has also been named one of the “500 Leading Dealmakers in America” by Lawdragon and a Metro New York Rising Star by Super Lawyers.
Mr. Zavaglia was born in Brooklyn, New York. He received a B.B.A. cum laude from the College of Insurance in 2001, and a J.D. summa cum laude from Brooklyn Law School in 2004. At Brooklyn Law School, Mr. Zavaglia was the valedictorian of his graduating class and a member of the Brooklyn Law Review. He joined Cravath in 2004 and was elected a partner in 2011. At Cravath, Mr. Zavaglia is Head of Leveraged Finance North America.
Representative capital markets transactions include representing:
Altra in $1.64 billion of senior secured credit facilities and its issuance of $400 million of high‑yield senior notes, and in committed debt financing for the $3 billion Reverse Morris Trust transaction combining Altra with Fortive’s Automation & Specialty platform business;
Mr. Zavaglia has also represented private and public companies in connection with mergers and acquisitions matters, takeover defense and unsolicited change in control transactions.
Representative M&A transactions include representing (among others):
Diversity is a hallmark of Mr. Zavaglia’s practice. Bucking the industry trend towards specialization, Mr. Zavaglia instead maintains a broad‑based corporate practice and advises his clients on their most significant matters—regardless of industry or manner of transaction.
Mr. Zavaglia has been repeatedly recognized for his work by Chambers USA, Chambers Global, The Legal 500 US, IFLR1000 and Super Lawyers. According to clients, Mr. Zavaglia is “among the leading names in the market” with an “excellent reputation.” Clients have described him as “top-notch” and someone who “never fails to impress and delivers the best outcomes for his clients.” Mr. Zavaglia has been named by IFLR1000 as a Market Leader and recognized as both a Leading Lawyer and a Rising Star. He has also been named one of the “500 Leading Dealmakers in America” by Lawdragon and a Metro New York Rising Star by Super Lawyers.
Mr. Zavaglia was born in Brooklyn, New York. He received a B.B.A. cum laude from the College of Insurance in 2001, and a J.D. summa cum laude from Brooklyn Law School in 2004. At Brooklyn Law School, Mr. Zavaglia was the valedictorian of his graduating class and a member of the Brooklyn Law Review. He joined Cravath in 2004 and was elected a partner in 2011. At Cravath, Mr. Zavaglia is Head of Leveraged Finance North America.
Representative capital markets transactions include representing:
Altra in $1.64 billion of senior secured credit facilities and its issuance of $400 million of high‑yield senior notes, and in committed debt financing for the $3 billion Reverse Morris Trust transaction combining Altra with Fortive’s Automation & Specialty platform business;
Mr. Zavaglia has also represented private and public companies in connection with mergers and acquisitions matters, takeover defense and unsolicited change in control transactions.
Representative M&A transactions include representing (among others):
Chambers Global
Chambers USA
IFLR1000
Lawdragon
The Legal 500 US
Super Lawyers
Deals & Cases
August 18, 2025
Cravath represented the initial purchasers in connection with the $1.79 billion 144A/Reg. S high‑yield senior secured notes offering of CHS/Community Health Systems, Inc. CHS/Community Health Systems, Inc., together with its parent company, Community Health Systems, Inc., is one of the nation’s largest healthcare companies. Cravath also represented the dealer manager in connection with the concurrent $1.47 billion cash tender offer. The transactions closed on August 12, 2025.
Deals & Cases
August 11, 2025
Cravath represented Symetra Life Insurance Company (“Symetra Life”) in connection with its $500 million 144A/Reg. S surplus notes offering. Symetra Life is a wholly owned subsidiary of Symetra Financial Corporation, a financial services company in the life insurance industry. The transaction closed on July 24, 2025.
Deals & Cases
July 15, 2025
Cravath represented the administrative agent and lead arrangers in connection with the arrangement of $1.42 billion and €1.29 billion of term loan facilities made available to Aggreko, a portfolio company of I Squared Capital and TDR Capital and a global leader in energy solutions, providing rapidly deployable, temporary and semi permanent modular power and temperature control solutions, with strong diversification across customers, geographies and end‑markets. The transaction closed on July 1, 2025.
Deals & Cases
June 23, 2025
Cravath represented ODDITY Tech in connection with the $600 million Rule 144A exchangeable senior notes offering by Oddity Finance LLC, guaranteed by ODDITY Tech Ltd. and IM Pro Makeup NY L.P. Oddity Finance LLC is a wholly owned, indirect subsidiary of ODDITY Tech, a consumer technology company building digital‑first brands for the beauty and wellness industries worldwide. In addition, Cravath advised Oddity Finance LLC in connection with capped call transactions entered into in connection with the offering. The transaction closed on June 12, 2025.
Deals & Cases
June 23, 2025
Cravath represented Toll Brothers Finance Corp. in connection with its $500 million registered senior notes offering, fully guaranteed by Toll Brothers, Inc. and certain of its subsidiaries. Toll Brothers Finance Corp. is an indirect wholly owned subsidiary of Toll Brothers, Inc., which designs, builds, markets, sells and arranges financing for an array of luxury residential homes and communities. The transaction closed on June 10, 2025.
Publications
June 12, 2025
On June 11, 2025, Cravath prepared a memo for its clients entitled “SEC Solicits Public Comment on the Eligibility Criteria for Foreign Private Issuer Status.” The memo examines a concept release recently published by the U.S. Securities and Exchange Commission to seek public comment on whether to revise the “foreign private issuer” definition in light of shifting trends in the characteristics of the FPI population.
Joseph D. Zavaglia is a generalist corporate lawyer with more than 20 years of experience advising public and private companies and financial institutions across multiple disciplines, including IPOs and other capital markets transactions; leveraged loans (broadly syndicated and direct) and other complex financing arrangements; activism defense (shareholder and debtholder) and other liability management transactions; corporate governance and other Board of Director matters; public company reporting and other SEC matters; and joint ventures, acquisitions and other M&A transactions.
Diversity is a hallmark of Mr. Zavaglia’s practice. Bucking the industry trend towards specialization, Mr. Zavaglia instead maintains a broad‑based corporate practice and advises his clients on their most significant matters—regardless of industry or manner of transaction.
Mr. Zavaglia has been repeatedly recognized for his work by Chambers USA, Chambers Global, The Legal 500 US, IFLR1000 and Super Lawyers. According to clients, Mr. Zavaglia is “among the leading names in the market” with an “excellent reputation.” Clients have described him as “top-notch” and someone who “never fails to impress and delivers the best outcomes for his clients.” Mr. Zavaglia has been named by IFLR1000 as a Market Leader and recognized as both a Leading Lawyer and a Rising Star. He has also been named one of the “500 Leading Dealmakers in America” by Lawdragon and a Metro New York Rising Star by Super Lawyers.
Mr. Zavaglia was born in Brooklyn, New York. He received a B.B.A. cum laude from the College of Insurance in 2001, and a J.D. summa cum laude from Brooklyn Law School in 2004. At Brooklyn Law School, Mr. Zavaglia was the valedictorian of his graduating class and a member of the Brooklyn Law Review. He joined Cravath in 2004 and was elected a partner in 2011. At Cravath, Mr. Zavaglia is Head of Leveraged Finance North America.
Representative capital markets transactions include representing:
Altra in $1.64 billion of senior secured credit facilities and its issuance of $400 million of high‑yield senior notes, and in committed debt financing for the $3 billion Reverse Morris Trust transaction combining Altra with Fortive’s Automation & Specialty platform business;
Mr. Zavaglia has also represented private and public companies in connection with mergers and acquisitions matters, takeover defense and unsolicited change in control transactions.
Representative M&A transactions include representing (among others):
Diversity is a hallmark of Mr. Zavaglia’s practice. Bucking the industry trend towards specialization, Mr. Zavaglia instead maintains a broad‑based corporate practice and advises his clients on their most significant matters—regardless of industry or manner of transaction.
Mr. Zavaglia has been repeatedly recognized for his work by Chambers USA, Chambers Global, The Legal 500 US, IFLR1000 and Super Lawyers. According to clients, Mr. Zavaglia is “among the leading names in the market” with an “excellent reputation.” Clients have described him as “top-notch” and someone who “never fails to impress and delivers the best outcomes for his clients.” Mr. Zavaglia has been named by IFLR1000 as a Market Leader and recognized as both a Leading Lawyer and a Rising Star. He has also been named one of the “500 Leading Dealmakers in America” by Lawdragon and a Metro New York Rising Star by Super Lawyers.
Mr. Zavaglia was born in Brooklyn, New York. He received a B.B.A. cum laude from the College of Insurance in 2001, and a J.D. summa cum laude from Brooklyn Law School in 2004. At Brooklyn Law School, Mr. Zavaglia was the valedictorian of his graduating class and a member of the Brooklyn Law Review. He joined Cravath in 2004 and was elected a partner in 2011. At Cravath, Mr. Zavaglia is Head of Leveraged Finance North America.
Representative capital markets transactions include representing:
Altra in $1.64 billion of senior secured credit facilities and its issuance of $400 million of high‑yield senior notes, and in committed debt financing for the $3 billion Reverse Morris Trust transaction combining Altra with Fortive’s Automation & Specialty platform business;
Mr. Zavaglia has also represented private and public companies in connection with mergers and acquisitions matters, takeover defense and unsolicited change in control transactions.
Representative M&A transactions include representing (among others):
Chambers Global
Chambers USA
IFLR1000
Lawdragon
The Legal 500 US
Super Lawyers
Deals & Cases
August 18, 2025
Cravath represented the initial purchasers in connection with the $1.79 billion 144A/Reg. S high‑yield senior secured notes offering of CHS/Community Health Systems, Inc. CHS/Community Health Systems, Inc., together with its parent company, Community Health Systems, Inc., is one of the nation’s largest healthcare companies. Cravath also represented the dealer manager in connection with the concurrent $1.47 billion cash tender offer. The transactions closed on August 12, 2025.
Deals & Cases
August 11, 2025
Cravath represented Symetra Life Insurance Company (“Symetra Life”) in connection with its $500 million 144A/Reg. S surplus notes offering. Symetra Life is a wholly owned subsidiary of Symetra Financial Corporation, a financial services company in the life insurance industry. The transaction closed on July 24, 2025.
Deals & Cases
July 15, 2025
Cravath represented the administrative agent and lead arrangers in connection with the arrangement of $1.42 billion and €1.29 billion of term loan facilities made available to Aggreko, a portfolio company of I Squared Capital and TDR Capital and a global leader in energy solutions, providing rapidly deployable, temporary and semi permanent modular power and temperature control solutions, with strong diversification across customers, geographies and end‑markets. The transaction closed on July 1, 2025.
Deals & Cases
June 23, 2025
Cravath represented ODDITY Tech in connection with the $600 million Rule 144A exchangeable senior notes offering by Oddity Finance LLC, guaranteed by ODDITY Tech Ltd. and IM Pro Makeup NY L.P. Oddity Finance LLC is a wholly owned, indirect subsidiary of ODDITY Tech, a consumer technology company building digital‑first brands for the beauty and wellness industries worldwide. In addition, Cravath advised Oddity Finance LLC in connection with capped call transactions entered into in connection with the offering. The transaction closed on June 12, 2025.
Deals & Cases
June 23, 2025
Cravath represented Toll Brothers Finance Corp. in connection with its $500 million registered senior notes offering, fully guaranteed by Toll Brothers, Inc. and certain of its subsidiaries. Toll Brothers Finance Corp. is an indirect wholly owned subsidiary of Toll Brothers, Inc., which designs, builds, markets, sells and arranges financing for an array of luxury residential homes and communities. The transaction closed on June 10, 2025.
Publications
June 12, 2025
On June 11, 2025, Cravath prepared a memo for its clients entitled “SEC Solicits Public Comment on the Eligibility Criteria for Foreign Private Issuer Status.” The memo examines a concept release recently published by the U.S. Securities and Exchange Commission to seek public comment on whether to revise the “foreign private issuer” definition in light of shifting trends in the characteristics of the FPI population.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.